- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05399563
Medico-legal Assessment of Sexual Violence-Assiut University
June 19, 2022 updated by: Ahmed Mohamed Ahmed Othman, Assiut University
Medico-legal Assessment of Sexual Violence and Pregnancy Related Allegations Among Females Presented to Women's Health Hospital -Assiut University
- Medico legal assessment of sexual assaults allegations of females presented to hospital and any associated violence.
- Assessment of cases of pregnancy associated violence with other related complications that have both medical and legal implications.
- Knowing role of VAW Unit in compacting female abuse offering support and authentication of suspicious claims
Study Overview
Detailed Description
The data will be obtained after informed consents from cases. These cases will be then analyzed in terms of:
- Verifying legal procedures as careful reviewing of public prosecution order and associated victim's identification documents if present
- Obtain a detailed history including personal information as age, marital status' residence and education; incident circumstances like assault characteristics as numbers of assailants, relationship to the victim' place of assault' frequency of assault and the time lapse between examination and last assault, etc ; gynecologic and obstetric history.
- General examination that include proper documentation of all visible injuries all over the body (type' direction' location' shape) and local examination of genital or anal region and possibility of taking vaginal and anal swabs if possible.
- Re-examined victim after two weeks for exclude any venereal diseases and doing pregnancy test.
Study Type
Observational
Enrollment (Anticipated)
50
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
As nature of a descriptive study design; All eligible cases of substance abuse admitted to Women Health Hospital and Safe Women's Unit belong to Assiut will be examined for inclusion and exclusion criteria.
The cases will be included in the study in duration of one year (March 2022- February 2023).
Description
Inclusion Criteria:
- All females above ≥ 12 years old with suspicious sexual violence or illegal pregnancy or criminal induction of abortion.
Exclusion Criteria:
- All females who will present to the women's health hospital above 12 years old for ordinary medical advice or treatment of gynecologic or obstetric complaints
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Ecologic or Community
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measure the prevalence of sexual violence problem among females
Time Frame: from 1-6-2022 to 28-5-2023
|
These cases will be then analyzed in terms of Verifying legal procedures as careful reviewing of public prosecution order and associated victim's identification documents if present
|
from 1-6-2022 to 28-5-2023
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
July 1, 2022
Primary Completion (Anticipated)
May 28, 2023
Study Completion (Anticipated)
May 28, 2023
Study Registration Dates
First Submitted
March 21, 2022
First Submitted That Met QC Criteria
May 27, 2022
First Posted (Actual)
June 1, 2022
Study Record Updates
Last Update Posted (Actual)
June 22, 2022
Last Update Submitted That Met QC Criteria
June 19, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- a100
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attempted Rape of Female
-
University Hospital, MontpellierINSERM U960 - Cognitive Neuroscience Laboratory - Paris, FranceTerminatedDepression | History of Suicide AttemptFrance
-
University of WashingtonAmerican Foundation for Suicide Prevention; The Catholic University of AmericaCompletedQuality of Life | Suicidal Ideation | Suicide, Attempted | Distress, Psychological
-
University Hospital, BrestCompletedPrevention of the SuicideFrance
-
Rigshospitalet, DenmarkMinistry of Social Affairs, DenmarkUnknownSuicidal Behaviour | Repetition of Suicidal BehaviourDenmark
-
University of BernRecruitingSuicidal Ideation | Suicide, Attempted | Self Efficacy | Attention | Locus of Control | Inhibitory ControlSwitzerland
-
University of BernRecruitingSuicide, Attempted | Self Efficacy | Suicide Ideation | Locus of Control | Inhibitory Control | Process Factors | Movement SynchronySwitzerland
-
Assistance Publique - Hôpitaux de ParisCompletedPregnant Women Undergoing TOP | TOP - Failed Attempted Termination of PregnancyFrance
-
Universitaire Ziekenhuizen KU LeuvenUniversity of Sydney; University of CagliariActive, not recruitingEndometriosis | Surgery | Gynecologic Disease | Endometriosis, Rectum | Endometriosis of Vagina | Endometriosis Rectovaginal Septum | Endometriosis of Colon | Endometriosis of BladderBelgium, Italy, Australia
-
M.D. Anderson Cancer CenterPacira Pharmaceuticals, IncTerminatedGynecologic Cancer | Malignant Neoplasms of Female Genital OrgansUnited States